Target intelligence / Profile preview

Reactive oxygen species and ROS-generating systems (ROS)

Target
ROS
Molecular classification
Enzyme, Other (Reactive chemical species)
01

Overview

Reactive oxygen species (ROS) are highly reactive oxygen-containing molecules, such as superoxide radicals and hydrogen peroxide, that are generated as natural byproducts of cellular metabolism (NCBI, PMC3070774). ROS-generating systems include enzymes like NADPH oxidases (NOX), xanthine oxidase, and the mitochondrial electron transport chain, which play vital roles in cell signaling and the immune response (PubMed, 22703241). However, an imbalance between ROS production and antioxidant defenses leads to oxidative stress, which causes damage to DNA, proteins, and lipids (NIH, 2023). This damage is a key driver in the pathogenesis of various conditions, including cancer, cardiovascular diseases, and neurodegenerative disorders like Alzheimer's (PubMed, 28249118). Therapeutic interventions target these systems through direct scavenging of radicals, inhibition of ROS-producing enzymes, or the induction of endogenous antioxidant pathways (PubChem). Despite their potential, therapeutic targeting is complicated by the need to preserve physiological ROS levels required for normal cellular communication and host defense (PubMed, 23953108).

Other names
OxidantsReactive oxygen metabolitesOxygen free radicalsPro-oxidantsOxidative stress systems
02

Mechanism of action

Mechanisms include direct neutralization of reactive species (scavenging), inhibition of enzymatic sources such as NADPH oxidase or xanthine oxidase, and pharmacological activation of the Nrf2-mediated antioxidant response.

03

Biological functions

Signal transductionImmune responseApoptosisCell deathRedox homeostasis
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetes
05

Safety considerations

Inhibition of physiological redox signalingPotential pro-oxidant effects at high dosesLack of tissue or enzyme specificityImpairment of immune-mediated pathogen killing (oxidative burst)
06

Interacting drugs

N-acetylcysteine

5 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)8-IsoprostaneProtein carbonylsGlutathione/Glutathione disulfide (GSH/GSSG) ratio

Beyond the preview

Go deeper on Reactive oxygen species and ROS-generating systems (ROS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and ROS-generating systems (ROS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call